Dasatinib Teva

Medicinal product

(Invented) name

Dasatinib Teva

Active substance (s)

Dazatinibas

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA02, dasatinib

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2019-02-08

Date of renewal

2023-05-08

Documents

4329_Dasatinib Teva_perr2023-05-08.docx

4329_pakuotes lapelis_2023-05-08.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NO/H/0279/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Dazatinibas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
100925	87036	1087036	lizdinė plokštelė	N30		Receptinis	LT/1/19/4329/001	Netiekiama	-	-	No	-	-
100926	87037	1087037	lizdinė plokštelė	N60		Receptinis	LT/1/19/4329/002	Tiekiama	2025-06-23	-	No	-	-	Download
100927	87038	1087038	dalomoji lizdinė plokštelė	N56x1		Receptinis	LT/1/19/4329/003	Netiekiama	-	-	No	-	-
100928	87039	1087039	dalomoji lizdinė plokštelė	N60x1		Receptinis	LT/1/19/4329/004	Netiekiama	-	-	No	-	-
100929	87040	1087040	buteliukas	N60		Receptinis	LT/1/19/4329/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-05-08	Perregistruotas
2019-02-08	Registruotas